Comparison of gelatin and HES 130/0.4 solution for fluid resuscitation in children with dengue shock syndrome

  • Merry Mawardi Department of Child Health, Sam Ratulangi University Medical School
  • Tony Rampengan Department of Child Health, Sam Ratulangi University Medical School
  • Jeanette Manoppo Department of Child Health, Sam Ratulangi University Medical School
  • Novie Homenta Rampengan Department of Child Health, Sam Ratulangi University Medical School
Keywords: dengue shock syndrome, resuscitation, gelatin, HES 130/0.4

Abstract

Background Dengue shock syndrome (DSS) is characterized
by severe vascular leakage and hemostasis disorder, which causes
death in 1-5% of cases. World Health Organization management
guidelines for fluid resuscitation in DSS remain empirical, rather
than evidence-based.
Objective To as sess the efficacy of ge latin compared to
hydroxyethyl starch (HES) 130/0.4 solution for fluid resuscitation
in children with DSS.
Methods We performed a multi-centered, randomized study to
compare gelatin and HES 130/0.4 solution for resuscitation of
children with DSS. We randomly assigned 25 children with DSS
to receive gelatin fluid and 25 children to receive HES 130/0.4.
Statistical analyses were performed using Chi-square and MannWhitney
tests.
Results More rapid increase in pulse pressure was noted in
subjects treated with HES 130/0.4 compared to those treated
with gelatin at 8 hours and 28 hours of therapy (P=0.037 and
P=0.048). The decrease in hematocrit in subjects treated with
HES 130/0.4 was faster than that of gelatin at 4 hours of therapy
(P=0.001). One patient died due to an unusual manifestation of
DSS. Respiratory rate decreased faster in subjects treated with
HES 130/0.4 than those treated with gelatin at 4 hours and 8
hours of therapy (P< 0.05). Body temperature remained higher
in subjects treated with gelatin than HES 130/0.4 at 36 hours and
48 hours of therapy (P< 0.05). However, the decrease in platelet
counts in subjects treated with HES 130/0.4 was more than that
of gelatin (P=0.018).
Conclusion HES 130/0.4 solution may be better for volume replacement
compared to gelatin and is safe for fluid resuscitation
in children with DSS.

References

l. WHO. Dengue haemorrhagic fever, treatment, prevention
and control. 2"d ed. Geneva: WHO; 1997.
2. Halstead SB. Epidemiology of dengue haemorrhagic fever.
In: Gubler DJ, Kuna G, editors. Dengue and dengue
haemorrhagic fever. England: CAB Int; 1997. p. 23-44.
3. Rampengan TH. Demam berdarah dengue. In: Rampengan
TH, Laurens IR, editors. Penyakit infeksi tropik pada anak.
Jakarta: EGC; 2002. p.135-55.
4. Setiati T E. Pengelolaan syok pada demam berdarah dengue.
In: Sutatyo, Pudjo HW, Mulatsih S, editors. Tatalaksana syok
clan perdarahan pada DBD. Yogyakarta: Medika FK UGM;
2004. p. 75-85.
5. Sumarrno. Demam berdarah dengue pada anak [dissertation].
Uakarta): UI Press; 1983; p. 20-5.
6. Dung NM, Day NP, Tam DT, Loan HT, Chau HT, Minh
LN, et al. Fluid replacement in dengue shock syndrome: a
randomized, double-blind comparison of four intravenous fluid
regimens. Clin Infect Dis. 1999;29:787-94.
7. Ngo NT, Cao J, Kneen R, Wills B, Ngyuyen VM, Ngyuyen
TQ, et al. Acute management of dengue shock syndrome: a
randomized double-blind comparison of four intravenous fluid
regimens in the first hour. Clin Infect Dis. 2001;32:204-13.
8. Barclay L, Lie D. Ringer's lactate maybe quivalent to colloid
for maderate dengue shock syndrome in children. N Engl J
Med. 2005 ;363 :57 7 -89.
9. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT,
et al. Comparison of three fluid solutions for resuscitation in
dengue shock syndrome. N Engl J Med. 2005 ;353:877-89.
10. Prasetyo RV, Aziz AL, Soegijanto S. Comparison of efficacy
and safety ofhydroxyethyl starch 130/0.4 and Ringer's lactate
in children with grade III dengue hemorrhagic fever. Paediatr
Indones. 2009;49:103.
11. Pudjiadi A. Koloid clan kristaloid. In: Trihono P, Purnawati
S, Syarif DR, editors. Hot topics in pediatrics II. Jakarta:
PUBLISHER. 2002; p. 121-133.
12. Beards SC, Watt T, Edwards JP, Nightingale P, Farragher
EB. Comparison of the hemodynamic and oxygen transport
responses to modified fluid gelatin and hetastarch in critically
ill patients: a prospective, randomized trial. Crit Care Med.
1994;22:600-5.
13. Sumpelmann R, Kretz FJ, Gabler R, Luntzer R, Baroncini
S, Osterkorn D, et al. Hydroxyethyl starch 130/0.42/6: l
for perioperative plasma volume replacement in children :
preliminary results of a European prospective multicenter
observational postauthorization safety study (PASS). Paediatr
Anaesth. 2008; 18:929-33.
14. Laxenaire M, Verra MD, Jalac SL. The use ofcolloids and crystalloids
in pediatric dengue shock syndrome: a systematic review
and meta-analysis. Intensive Care Med. 20 10;39: 14-25.
15. Boldt J, Preibe HJ. Intravascular volume replacement therapy
with synthetic colloids: is there an influence on ren al
function? Anesth Analg. 2003 ;96:3 7 6-82.
16. Molyneux EM, Maitland K. Intravenous fluids-getting the
balance right. N EnglJ Med. 2005;353: 941-4.
17. Sumpelmann R, Witt L, Brutt M, Osterkorn D, Koppert
W, Osthaus WA. Chan ges in acid-base, electrolyte and
hemoglobin concentrations during infusion ofhydroxyethyl
starch 130/0 .42/6: l in normal saline or in balanced
electrolyte solu tion in children. Paediatr Anaesth.
20 10;20 :100-4.
Published
2013-12-30
How to Cite
1.
Mawardi M, Rampengan T, Manoppo J, Rampengan N. Comparison of gelatin and HES 130/0.4 solution for fluid resuscitation in children with dengue shock syndrome. PI [Internet]. 30Dec.2013 [cited 25Jul.2024];53(6):328-3. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/372
Received 2016-08-29
Accepted 2016-08-29
Published 2013-12-30